Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Merck KGaA.

Community Practice Connections™: 4th Annual European Congress on Immunotherapies in Cancer™

Release Date: December 20, 2019
Expiration Date: December 20, 2020
Media: Internet - based

Activity Overview

Immunotherapy has rapidly become a mainstay of cancer care across the spectrum of tumor types. The role of immunotherapy in the real-world setting has been informed by clinical trial data, but the expanding use of these treatment options in the clinic requires expert perspective to apply the available data to a broader patient population. In this activity, key highlights in immune-related adverse events and biomarker-driven care across melanoma, colorectal cancer, and lung cancer will be reviewed and discussed by expert faculty.

Benefits of Participating

  • Identify the latest updates on the role of immunotherapy in lung cancer, melanoma, and colorectal cancer
  • Gain expert perspective on the application of immunotherapy to patient populations that exist outside the spectrum of clinical trial eligibility
  • Learn about emerging data regarding ongoing research to incorporate biomarkers that identify patients most likely to benefit from immunotherapy

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Merck KGaA.

Instructions for This Activity and Receiving Credit

  • You will need to log in to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review videos/content until you finish the presentation.
  • At the end of the activity, “Educational Content/Videos” will be available for your reference.
  • To receive a CME Certificate, you must complete the activity.
  • Complete the Posttest and pass with a score of 70% or higher, complete the Evaluation, and then click on “Request for Credit.” You may immediately download a CME Certificate upon completion of these steps.

Target Audience

This educational activity is intended for medical oncologists and other healthcare professionals (physicians, physicians-in-training, oncology nurses, pharmacists, physician assistants, etc). Participants will primarily be those whose practice requires mastery and a critical understanding of the fundamental principles, pivotal published studies, and emerging information on immunotherapies and their evolving roles in the treatment of cancer.

Learning Objectives

Upon successful completion of this educational activity, you should be better prepared to:

  • Describe targets and mechanisms of immunotherapeutic agents in oncology
  • Identify key findings of recent clinical trials relevant to immunotherapy across malignancies
  • Outline ongoing studies of immunotherapy and the gaps in understanding of efficacy and safety these trials are meant to address
  • List biomarkers and patient-specific factors that may affect response to immunotherapeutic treatment
  • Define evidence-based treatment strategies to mitigate and prevent immune-mediated adverse events with immunotherapeutic agents across malignancies

Faculty, Staff, and Planners’ Disclosures


Caroline Robert
Caroline Robert, MD, PhD
Professor of Dermatology
Paris-Sud Univeristy
Head of the Dermatology Unit
Department of Medicine
Institut Gustave Roussy
Paris, France

Disclosures: Consultant: Amgen, Bristol-Myers Squibb, Merck, Novartis, Pierre Fabre, Roche.

Alex Duval
Alex Duval, MD, PhD
Full Professor of Molecular Oncology Director, INSERM Team "Instability of Microsatellites and Cancer”
Saint-Antoine Research Center - UMRS 938
French Institute of Health and Medical Research
Paris, France

Disclosures: no relevant financial relationships with commercial interests to disclose.

Roman Perez-Soler
Roman Perez-Soler, MD
Chairman, Department of Oncology
Chief, Division of Medical Oncology
Montefiore Medical Center
Professor of Medicine
Deputy Director, Albert Einstein Cancer Center
Albert Einstein College of Medicine
Bronx, New York, USA

Disclosures: Grant Research Support: National Cancer Institute; Consultant: Adgero Biopharmaceuticals, AstraZeneca, Boehringer Ingelheim, Clovis Oncology, GlaxoSmithKline, Lilly, Roche/Genentech; Shareholder: Stelexis Therapeutics.

The staff of Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, PER® makes it a policy to ensure fair balance, independence, objectivity, and scientific rigor in all its CME activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that create a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for CME purposes only and is not meant to substitute for the independent clinical judgment of a physician relative to diagnostic or treatment options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or the company that provided commercial support.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By